• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估针对风疹病毒中和域的抗体以确定免疫状态。

Evaluation of antibodies against a rubella virus neutralizing domain for determination of immune status.

作者信息

Cordoba P, Lanoel A, Grutadauria S, Zapata M

机构信息

Instituto de Virologia, Facultad de Ciencias Médicas, Universidad Nacional de Cordoba, Cordoba, Argentina.

出版信息

Clin Diagn Lab Immunol. 2000 Nov;7(6):964-6. doi: 10.1128/CDLI.7.6.964-966.2000.

DOI:10.1128/CDLI.7.6.964-966.2000
PMID:11063507
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC95994/
Abstract

The protective immune responses against rubella virus (RV) are related to its neutralizing epitopes, an issue that is important to consider when assessing the immune status of patients with remote infection. In the present paper, we compare the antibodies detected by a synthetic-peptide-based enzyme immunoassay (EIA) with antibodies detected by the traditional technique of hemagglutination inhibition (HIA) in patients with remote RV infection. The synthetic peptide used as an antigen (SP15) represents a neutralizing epitope that corresponds to amino acids 208 to 239 of the E1 glycoprotein. The SP15-EIA was developed, all variables that affected the assay were standardized, and the test was validated using reference sera. Serum samples (n = 129) from patients with remote RV infection were tested by HIA and SP15-EIA. Discrepant sera were assayed by MEIA (IMX/Abbot). The comparison between HIA and SP15-EIA, taking HIA as the standard methodology for determining immune status, showed that SP15-EIA is very specific and sensitive for detecting protecting antibodies (specificity, 100%; sensitivity, 98.20%). This study demonstrates that antibodies against the neutralizing domain represented by SP15 would be important in the memory response after natural infection and may be a good tool in the determination of the true immune status of patients with remote infection with regard to RV.

摘要

针对风疹病毒(RV)的保护性免疫反应与其中和表位有关,这是评估远期感染患者免疫状态时需要考虑的一个重要问题。在本文中,我们比较了基于合成肽的酶免疫测定法(EIA)和传统血凝抑制技术(HIA)在远期RV感染患者中检测到的抗体。用作抗原的合成肽(SP15)代表一个中和表位,对应于E1糖蛋白的第208至239位氨基酸。我们开发了SP15-EIA,对影响该测定的所有变量进行了标准化,并使用参考血清对该检测方法进行了验证。对远期RV感染患者的血清样本(n = 129)进行了HIA和SP15-EIA检测。对有差异的血清样本采用微粒子酶免疫分析法(MEIA,IMX/雅培)进行检测。以HIA作为确定免疫状态的标准方法,对HIA和SP15-EIA进行比较,结果显示SP15-EIA在检测保护性抗体方面具有很高的特异性和敏感性(特异性为100%;敏感性为98.20%)。本研究表明,针对由SP15代表的中和结构域的抗体在自然感染后的记忆反应中具有重要作用,并且在确定远期RV感染患者的真实免疫状态方面可能是一个很好的工具。

相似文献

1
Evaluation of antibodies against a rubella virus neutralizing domain for determination of immune status.评估针对风疹病毒中和域的抗体以确定免疫状态。
Clin Diagn Lab Immunol. 2000 Nov;7(6):964-6. doi: 10.1128/CDLI.7.6.964-966.2000.
2
Comparison of a whole-virus enzyme immunoassay (EIA) with a peptide-based EIA for detecting rubella virus immunoglobulin G antibodies following rubella vaccination.全病毒酶免疫测定法(EIA)与基于肽的酶免疫测定法在检测风疹疫苗接种后风疹病毒免疫球蛋白G抗体方面的比较。
J Clin Microbiol. 1993 Jun;31(6):1521-4. doi: 10.1128/jcm.31.6.1521-1524.1993.
3
Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals.风疹再免疫:对既往血清学阴性和血清学阳性个体接种风疹病毒疫苗后免疫球蛋白G反应的比较分析。
J Clin Microbiol. 1996 Sep;34(9):2210-8. doi: 10.1128/jcm.34.9.2210-2218.1996.
4
Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay.利用基于新型合成肽的酶联免疫吸附测定法对风疹病毒特异性抗体反应进行表征。
J Clin Microbiol. 1992 Jul;30(7):1841-7. doi: 10.1128/jcm.30.7.1841-1847.1992.
5
An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain.一个由抗体和合成肽定义的风疹病毒E1糖蛋白中和结构域。
J Virol. 1993 Feb;67(2):961-8. doi: 10.1128/JVI.67.2.961-968.1993.
6
Presence of a neutralizing domain in isolates of rubella virus in Cordoba, Argentina.阿根廷科尔多瓦风疹病毒分离株中存在中和结构域。
Clin Diagn Lab Immunol. 1997 Jul;4(4):493-5. doi: 10.1128/cdli.4.4.493-495.1997.
7
Selective tolerance to the E1 protein of rubella virus in congenital rubella syndrome.先天性风疹综合征中对风疹病毒E1蛋白的选择性耐受
J Immunol. 1993 Aug 15;151(4):2041-9.
8
A synthetic peptide ELISA for the screening of rubella virus neutralizing antibodies in order to ascertain immunity.
J Immunol Methods. 2004 Apr;287(1-2):1-11. doi: 10.1016/j.jim.2003.12.011.
9
Comparison of hemagglutination inhibition assay and enzyme immunoassay for determination of mumps and rubella immune status in health care personnel.比较血凝抑制试验和酶免疫分析法在检测医护人员腮腺炎和风疹免疫状态中的应用。
J Clin Lab Anal. 2013 Sep;27(5):418-21. doi: 10.1002/jcla.21621.
10
E1 glycoprotein of rubella virus carries an epitope that binds a neutralizing antibody.风疹病毒的E1糖蛋白携带一个可与中和抗体结合的表位。
J Virol Methods. 1985 Dec;12(3-4):243-50. doi: 10.1016/0166-0934(85)90135-1.

引用本文的文献

1
Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial].一项 1/2 期、单中心、双盲、双模拟、随机、阳性对照、年龄递减试验的研究方案,旨在评估麻疹和风疹减毒活疫苗微针贴片在健康成年人(18 至 40 岁)、麻疹和风疹疫苗初免幼儿(15 至 18 个月)和麻疹和风疹疫苗初免婴儿(9 至 10 个月)中的安全性、耐受性和免疫原性[麻疹和风疹疫苗微针贴片 1/2 期年龄递减试验]。
Trials. 2022 Sep 14;23(1):775. doi: 10.1186/s13063-022-06493-5.
2
T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.T 淋巴细胞作为针对病毒疾病的保护和疫苗接种的可衡量靶标。
Int Rev Cell Mol Biol. 2019;342:175-263. doi: 10.1016/bs.ircmb.2018.07.006. Epub 2018 Oct 24.
3
Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.使用蛋白质组芯片技术对两剂麻疹-腮腺炎-风疹疫苗接种后的风疹特异性体液免疫进行表征。
PLoS One. 2017 Nov 16;12(11):e0188149. doi: 10.1371/journal.pone.0188149. eCollection 2017.
4
Rubella.风疹
Lancet. 2015 Jun 6;385(9984):2297-307. doi: 10.1016/S0140-6736(14)60539-0. Epub 2015 Jan 8.

本文引用的文献

1
Rubella reinfection; role of neutralising antibodies and cell-mediated immunity.
Clin Diagn Virol. 1994 Oct;2(6):349-58. doi: 10.1016/0928-0197(94)90005-1.
2
Synthetic-peptide-based enzyme-linked immunosorbent assay for screening human serum or plasma for antibodies to human immunodeficiency virus type 1 and type 2.基于合成肽的酶联免疫吸附测定法,用于筛查人血清或血浆中的1型和2型人类免疫缺陷病毒抗体。
Clin Diagn Lab Immunol. 1997 Sep;4(5):598-603. doi: 10.1128/cdli.4.5.598-603.1997.
3
Presence of a neutralizing domain in isolates of rubella virus in Cordoba, Argentina.阿根廷科尔多瓦风疹病毒分离株中存在中和结构域。
Clin Diagn Lab Immunol. 1997 Jul;4(4):493-5. doi: 10.1128/cdli.4.4.493-495.1997.
4
Different affinity of monoclonal antibodies for conserved neutralizing epitopes on two strains of rubella virus.
Viral Immunol. 1997;10(2):103-10. doi: 10.1089/vim.1997.10.103.
5
Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS.发展中国家风疹及先天性风疹综合征(CRS)的防控,第1部分:CRS的疾病负担
Bull World Health Organ. 1997;75(1):55-68.
6
Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals.风疹再免疫:对既往血清学阴性和血清学阳性个体接种风疹病毒疫苗后免疫球蛋白G反应的比较分析。
J Clin Microbiol. 1996 Sep;34(9):2210-8. doi: 10.1128/jcm.34.9.2210-2218.1996.
7
Comparison of a whole-virus enzyme immunoassay (EIA) with a peptide-based EIA for detecting rubella virus immunoglobulin G antibodies following rubella vaccination.全病毒酶免疫测定法(EIA)与基于肽的酶免疫测定法在检测风疹疫苗接种后风疹病毒免疫球蛋白G抗体方面的比较。
J Clin Microbiol. 1993 Jun;31(6):1521-4. doi: 10.1128/jcm.31.6.1521-1524.1993.
8
An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain.一个由抗体和合成肽定义的风疹病毒E1糖蛋白中和结构域。
J Virol. 1993 Feb;67(2):961-8. doi: 10.1128/JVI.67.2.961-968.1993.
9
Rubella virus contains one capsid protein and three envelope glycoproteins, E1, E2a, and E2b.风疹病毒包含一种衣壳蛋白和三种包膜糖蛋白,即E1、E2a和E2b。
J Virol. 1983 Jun;46(3):964-73. doi: 10.1128/JVI.46.3.964-973.1983.
10
Antibody response to individual rubella virus proteins in congenital and other rubella virus infections.先天性风疹病毒感染及其他风疹病毒感染中针对风疹病毒单个蛋白的抗体反应。
J Clin Microbiol. 1985 Mar;21(3):449-51. doi: 10.1128/jcm.21.3.449-451.1985.